Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1362 studies found for:    "Hepatitis, Chronic"
Show Display Options
Rank Status Study
21 Completed CHARM: Chronic Hepatitis B Antihepadnaviral Resistance Mutation Study
Condition: Chronic Hepatitis B
Intervention: Other: No intervention
22 Completed Study of Nitazoxanide in the Treatment of Chronic Hepatitis C
Condition: Chronic Hepatitis C
Intervention: Drug: Nitazoxanide
23 Unknown  Early Prediction of Successful Treatment for Chronic Hepatitis C Virus Infection in Taiwan
Condition: Chronic Hepatitis C
Intervention: Drug: Pegylated interferon alfa and ribavirin
24 Unknown  Safety and Efficacy of Telbivudine on Liver Cirrhosis in Patients With Chronic Hepatitis B (CHB)
Conditions: Liver Cirrhosis;   Chronic Hepatitis B
Intervention: Drug: telbivudine
25 Active, not recruiting Vitamin D Deficiency in Subjects With Chronic Hepatitis C Compared to Healthy Volunteers
Condition: Chronic Hepatitis C
Intervention:
26 Enrolling by invitation Efficacy of Medical Ozone Therapy in Patients With Chronic Hepatitis B
Condition: Chronic Hepatitis B
Interventions: Device: medical ozone therapy with tianyi;   Device: medical ozone therapy with humares;   Drug: Diammonium glycyrrhizinate Capsules
27 Terminated Plasma Ribavirin Assay During Combination Therapy for Chronic Hepatitis C
Condition: Chronic Hepatitis C
Intervention: Procedure: therapeutic drug monitoring of ribavirin and dose adaptation
28 Recruiting Prospective Observational Cohort Study for the Durability of Anti-viral Therapy in Patients With Chronic Hepatitis B
Condition: Chronic Hepatitis B
Intervention:
29 Completed Pegylated Interferon Plus Ribavirin in Treating Older Patients With Chronic Hepatitis C
Condition: Chronic Hepatitis C
Interventions: Drug: pegylated interferon alpha and plus ribavirin;   Drug: pegylated interferon alpha and plus ribavirin
30 Completed Trial of Lamivudine Treatment in HBeAg Negative Chronic Hepatitis B Patients (in Asia)
Condition: Chronic Hepatitis B
Intervention: Drug: Lamivudine/ Placebo 100mg daily
31 Completed Microarray Analysis of IFN-Induced Gene Expression in Obese and Non-Obese Patients With Chronic Hepatitis C
Conditions: Chronic Hepatitis C;   Obesity
Intervention:
32 Completed
Has Results
Pegylated Interferon and Ribavirin to Treat Chronic Hepatitis C With and Without Kidney Disease
Condition: Chronic Hepatitis C
Interventions: Drug: Peginterferon alfa-2a with Ribavirin;   Drug: Peginterferon alfa-2a
33 Completed Prediction of Hepatic Fibrosis in Patients With Chronic Hepatitis C by Biochemical and Duplex Doppler Indices
Conditions: Chronic Hepatitis C;   Hepatic Fibrosis;   Cirrhosis
Intervention:
34 Unknown  A Trial To Study The Effect Of Lamivudine In Adult Patients Who Suffer From Chronic Hepatitis B Alone
Condition: Chronic Hepatitis B
Intervention: Drug: LAMIVUDINE
35 Recruiting Effect of Camel Milk on Chronic Hepatitis C
Condition: Chronic Hepatitis C
Interventions: Drug: Peginterferon,  Ribavirin, camel milk;   Drug: Peginterferon,  Ribavirin
36 Completed
Has Results
Efficacy and Safety Study of Ursodeoxycholic Acid to Treat Chronic Hepatitis C
Condition: Chronic Hepatitis C
Interventions: Drug: Ursodeoxycholic acid 150mg / day;   Drug: Ursodeoxycholic acid 600mg / day;   Drug: Ursodeoxycholic acid 900mg / day
37 Completed High Dose Ribavirin in the Treatment of Chronic Hepatitis C
Condition: Chronic Hepatitis C
Interventions: Drug: High ribavirin dose;   Drug: Standard ribavirin dose
38 Completed
Has Results
High-Dose Ribavirin and Peginterferon to Treat Chronic Hepatitis C Genotype 1
Condition: Chronic Hepatitis C
Interventions: Drug: Peginterferon;   Drug: Ribavirin
39 Recruiting PEG-interferon Alfa-2a add-on Study in HBeAg Negative Chronic Hepatitis B Patients
Condition: Chronic Hepatitis B
Interventions: Drug: Peginterferon alfa-2a;   Drug: Nucleos(t)ide analogue
40 Completed Interferon Treatment for Patients With Chronic Hepatitis C and End Stage Renal Disease
Conditions: Chronic Hepatitis C;   End Stage Renal Disease
Interventions: Drug: Peginterferon alfa-2a;   Drug: Interferon alfa-2a

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years